Clinical Research for Beginners: GCP & Clinical Trials

This module introduces the fundamentals of clinical research, clinical trials, and the drug development lifecycle. Learners will explore how new medicines progress from discovery and preclinical research through clinical development, regulatory review, and post-market monitoring. The module establishes the foundation needed to understand the broader clinical research process and clinical trial lifecycle.

Learning Objectives

• Define clinical research and explain its role in evidence-based healthcare.

• Describe the major stages of the drug development lifecycle.

• Understand the transition from preclinical research to clinical trials.

• Explain the purpose of clinical trials in evaluating new interventions.

• Identify key stakeholders involved in drug development and clinical research.

• Understand how regulatory review and post-market surveillance fit into drug development.

• Recognise the key components of the clinical trial lifecycle.

This module examines the history of human subjects research, clinical research ethics, research misconduct, and participant protection. Learners will explore key historical events that shaped modern research ethics and understand why Good Clinical Practice (GCP) and ethical standards are essential for protecting human research participants and maintaining scientific integrity.

Learning Objectives

• Explain the historical development of clinical research ethics.

• Identify major events that influenced modern human subjects research.

• Understand the ethical principles underlying research involving human participants.

• Recognise the importance of participant rights, safety, and well-being.

• Explain why Good Clinical Practice (GCP) was established.

• Understand how historical lessons shaped modern clinical trial regulations.

• Recognise the importance of ethical conduct and scientific integrity in clinical research.

This module introduces the fundamental principles of Good Clinical Practice (GCP), the internationally recognised standard for conducting ethical and scientifically sound clinical trials. Learners will explore how GCP protects participants while ensuring reliable, credible, and high-quality trial data.

Learning Objectives

• Explain the purpose and importance of GCP.

• Identify the core principles of GCP.

• Understand how GCP protects participant rights, safety, and well-being.

• Recognise the responsibilities of key trial stakeholders.

• Understand how GCP supports data quality and trial integrity.

• Identify the importance of compliance throughout the clinical trial lifecycle.

This module explores clinical trial regulations, research ethics, Institutional Review Boards (IRBs), informed consent, and participant protection. Learners will understand how regulatory and ethical oversight ensures clinical trials are conducted responsibly, protects human research participants, and maintains compliance with Good Clinical Practice (GCP) and applicable regulatory requirements.

Learning Objectives

• Explain the purpose of regulatory and ethical oversight in clinical research.

• Understand the role and responsibilities of Institutional Review Boards (IRBs).

• Explain the principles and process of informed consent.

• Identify key protections for human research participants.

• Understand how clinical trial regulations and GCP support participant safety.

• Recognise ethical considerations when designing and conducting clinical trials.

• Understand the importance of regulatory compliance and documentation in clinical research. 

This module introduces observational study designs used in epidemiology and clinical research. Learners will explore cohort, case-control, and cross-sectional studies, including their purposes, strengths, limitations, and appropriate applications in answering clinical and research questions.

Learning Objectives

• Define observational study designs and their role in clinical research.

• Explain the characteristics of cohort studies.

• Understand the design and application of case-control studies.

• Describe cross-sectional studies and their uses.

• Compare cohort, case-control, and cross-sectional study designs.

• Identify the strengths, limitations, and potential sources of bias in each design.

• Select an appropriate observational design for different clinical research questions.

This module introduces interventional studies, experimental study design, randomized controlled trials (RCTs), randomization, and blinding. Learners will understand how clinical trials are structured to evaluate interventions, reduce bias, establish reliable evidence, and assess the effectiveness and safety of treatments.

Learning Objectives

• Define interventional and experimental clinical studies.

• Explain the purpose and structure of randomized controlled trials (RCTs).

• Understand different approaches to randomization in clinical trials.

• Explain how randomization helps reduce selection bias and improve trial validity.

• Understand the principles and purpose of blinding and masking.

• Distinguish between common levels of clinical trial blinding.

• Recognise how RCT design supports reliable and scientifically valid clinical evidence.

This module explores clinical trial blinding, masking, and unblinding procedures and their role in reducing bias. Learners will understand different types of blinding, when unblinding may be necessary, and how appropriate procedures protect trial integrity, participant safety, and data reliability.

Learning Objectives

• Explain the purpose of blinding and masking in clinical trials.

• Distinguish between single-, double-, and other blinding approaches.

• Understand how blinding reduces bias in clinical research.

• Explain the principles and procedures of trial unblinding.

• Identify appropriate circumstances for emergency and planned unblinding.

• Understand how unblinding can affect trial integrity and data validity.

• Recognise the importance of documenting and controlling unblinding procedures.

This module explores clinical trial phases, drug development stages, and innovative clinical trial designs. Learners will understand the objectives of Phase I–IV clinical trials and how adaptive, basket, and platform trials can improve flexibility and efficiency in clinical research.

Learning Objectives

• Explain the purpose and characteristics of Phase I, II, III, and IV clinical trials.

• Understand how clinical trial phases support the drug development lifecycle.

• Identify the key objectives of each trial phase.

• Explain the basic principles of adaptive clinical trial designs.

• Understand the purpose and applications of basket trials.

• Explain the key features of platform trials.

• Recognise how innovative trial designs can improve clinical trial efficiency and flexibility.

This module explores clinical trial protocols, essential documents, and study documentation required to plan, conduct, document, and maintain compliance throughout a clinical trial. Learners will understand how accurate and complete documentation supports GCP compliance, participant safety, data integrity, and regulatory inspection readiness.

Learning Objectives

• Explain the purpose and structure of a clinical trial protocol.

• Identify key essential documents used in clinical research.

• Understand the importance of accurate and complete trial documentation.

• Recognise the role of source documents and study records.

• Understand how documentation supports GCP compliance and data integrity.

• Explain the importance of version control, record keeping, and document management.

• Recognise how proper documentation supports regulatory inspections and trial oversight.